Trexquant Investment LP Gamida Cell Ltd. Transaction History

Trexquant Investment LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.46 $89,559 - $181,562	-40,709 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.85 - $6.44 $102,949 - $172,205	26,740 Added 191.42%	40,709 $160,000
Q2 2021 Aug 12, 2021	BUY	$5.85 - $8.33 $81,718 - $116,361	13,969 New	13,969 $90,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.